Sarah Lawrence College

DigitalCommons@SarahLawrence
Human Genetics Theses

The Joan H. Marks Graduate Program in
Human Genetics

5-2016

The Utility of Genomic Variant Databases in Genetic Counseling
Colleen Ahern
Sarah Lawrence College

Elly Brokamp
Sarah Lawrence College

Follow this and additional works at: https://digitalcommons.slc.edu/genetics_etd
Part of the Other Genetics and Genomics Commons

Recommended Citation
Ahern, Colleen and Brokamp, Elly, "The Utility of Genomic Variant Databases in Genetic Counseling"
(2016). Human Genetics Theses. 15.
https://digitalcommons.slc.edu/genetics_etd/15

This Thesis - Open Access is brought to you for free and open access by the The Joan H. Marks Graduate Program
in Human Genetics at DigitalCommons@SarahLawrence. It has been accepted for inclusion in Human Genetics
Theses by an authorized administrator of DigitalCommons@SarahLawrence. For more information, please contact
alester@sarahlawrence.edu.

The Utility of Genomic Variant Databases in Genetic Counseling
Colleen Ahern and Elly Brokamp
Joan H. Mark Program in Human Genetics
Sarah Lawrence College
May 2016

“Submitted in partial completion of the Master of Science Degree at Sarah Lawrence College, May 2016”

The Utility of Genomic Variant Databases in Genetic Counseling
Colleen Ahern and Elly Brokamp
Abstract
Organizations such as the American College of Medical Genetics (ACMG) and the National
Society of Genetic Counselors (NSGC) are in agreement that public genomic data sharing
will benefit patient care. Despite these recommendations, not all clinical laboratories share
their variant data onto public databases. As the amount of genetic material being analyzed
for patient care continues to increase, more variants of unknown significance (VUS) are
reported as well. Genetic counselors need to properly interpret VUS results in order to aid
patients in making educated health decisions. For this paper, genetic counselors were asked
about genomic data sharing and how they handle VUS results for patients. While almost all
genetic counselors agree that there is a need for genomic data sharing, only some took
laboratories’ data sharing practices into account when deciding where to order testing.
Genetic counselors do not have a standard way of processing VUS results; there is little
consistency to how often genetic counselors look up variants in public databases or which
databases they use.
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Introduction/Background
Many organizations, clinicians, and laboratories believe that sharing genomic data is
important to research and patient care (Arias et al, 2015). On April 15 th, 2015 The National
Society of Genetic Counselors (NSGC) released a statement in favor of the transferring of
variant, phenotypic, and interpretative data quickly into public databases. NSGC states that,
“Timely data sharing in non-proprietary databases is essential to improve accuracy of
variant interpretation” (NSGC Headquarters, 2015). Other organizations also support this
belief. The American College of Medical Genetics (ACMG) also encourages clinical
laboratories to upload their information to databases in order to help gain more
information about variant classifications (Richards et al, 2015). Individual researchers and
clinicians have also expressed their support of the data sharing movement. As Dr. Robert
Nussbaum, Chief of the Division of Genomics at UCSF Medical Center summarizes, “it is
absolutely clear that sharing information provides better medical care” (http://www.freethe-data.org/learn).
Despite public opinion, not all laboratories place their information in public databases;
some prefer to use private databases for the purpose of competitive advantage or

convenience (Cook-Deegan et al, 2013). For example, Myriad Genetics ceased data sharing
in 2004 and has since maintained their own private databases, the largest repository of
variant information for the BRCA1 and BRCA2 genes (Nguyen et al, 2013). Through the
company’s 25 years of molecular testing they have tested over 2 million individuals and
created an internal variant classification system with 99.98% percent analytic sensitivity
(Myriad Genetics, 2016). Myriad claims that the variant data they have compiled over the
years puts their testing and variant classification method ahead of the competition (Matloff
et al, 2015). Some laboratories and clinicians feel that Myriad’s privatization of their BRCA1
and BRCA2 data hampers other laboratories ability to correctly classify variant information
resulting in diminished patient care (Nguyen et al, 2013).
In response to Myriad’s private database, other laboratories offering BRCA testing created
the Free the Data movement, which encourages clinicians, scientists, and patients to obtain
and share their genetic testing information (Nguyen et al, 2013). These laboratories choose
to advertise their data sharing methods in a hope that providers and patients will show a
preference toward laboratories that participate in data sharing (Matloff et al, 2015).
Whether or not this transparency has brought in more business for these laboratories has
not been analyzed.
One of the largest genomic databases currently available is ClinVar, a repository for variant
data from clinical laboratories, clinicians, expert groups, patients, researchers, and other
databases maintained by the National Institutes of Health. As of May 4th 2015, ClinVar had
172,055 variants submitted from 314 different submitters. Out of all the variants submitted,
11% have been submitted by at least two different sources. Of variants that have been
submitted more than once, 17% have conflicting classifications (Rehm et al, 2015).
Besides ClinVar, there are other broad variant databases. Online Mendelian Inheritance in
Man (OMIM) contains information on all known Mendelian disorders, focusing on the
relationship between genotype and phenotype. It is available to the public for free and is
updated daily (omim.org). Human Gene Mutation Database (HGMD) contains published
gene mutations that are associated with human inherited disease. It is a publically available,
up-to-date, comprehensive source of human gene mutations (Stenson et al, 2014). Leiden
Open Variation Database (LOVD) is an open source of DNA variations, even variations
outside of genes; LOVD is updated once a month (www.lovd.nl/3.0/home).
Population databases include sequence information from large populations and are not
disease or variant specific. They are used to find variant frequencies within a population or
more broadly. The 1000 Genomes Project was the first project to sequence a large number
of people’s genomes. Its goal is to find genetic variants that have at least a 1% frequency in

the general population, to provide a comprehensive resource on human genetic variation.
1000 Genome’s data is freely available online (www.1000genomes.org). Single Nucleotide
Polymorphism Database (dbSNP) is run by the National Center for Biotechnology
Information (NCBI). It contains short variations, including insertions/deletions and repeats,
in sequences from different types of organisms (http://www.ncbi.nlm.nih.gov/snp). Exome
Aggregation Consortium (ExAC) is a database containing sequence data from a variety of
projects. Its purpose is to make summary data widely available. It currently holds sequence
information on exomes from 60,706 individuals (exac.broadinstitute.org). The NHLBI GO
Exome Sequencing Project (ESP) also known as Exome Variant Server (EVS), is made up of
many collaborating groups with the goal of discovering genes that contribute to heart, lung,
and blood disorders (https://esp.gs.washington.edu/drupal/).
Locus specific databases are a curated listing of variants in a specific gene or causing a
specific disease. Breast Cancer Information Core (BIC) is a repository for variants causing
breast cancer run by National Human Genome Research Institute (NHGRI). Only members of
BIC have access to their database (http://research.nhgri.nih.gov/bic/).
Newer forms of genetic testing such as panel testing and whole exome/genome sequencing
are able to examine a large amount of the human genome, bringing along challenges in
interpreting results (Lerner-Ellis et al, 2015). Whole exome and whole genome sequencing is
the biggest challenge to properly interpreting genomic variants (Cook-Deegan et al, 2013).
Rather than the standard negative or positive test results these tests often identify genetic
variants that have not been seen before. In many cases it is not possible to interpret the
significance of these variants when they are first identified. These novel variants have been
termed variants of uncertain significance (VUS) (Aronson et al, 2012).
The correct VUS classification is important in the application of genetic testing to patient
clinical care. Guidelines for clinical practice depend greatly on the accurate classification of
actionable variants and their potential pathogenicity (Richards et al, 2015). The accuracy of
the interpretation and methodology varies and resulting discrepancies between labs calls
for improved standardization in variant classification (Craig et al, 2011). In order to help
patients make medical decisions, genetic counselors often cannot rely on laboratory results,
and are required to access the relevant databases and the assess the information available
on certain VUS results (Ormond et al, 2015).
The increase in the number of VUS results with which they must deal intensifies questions
about the approaches used by genetic counselors. Exactly how genetic counselors are
processing VUS results is still unknown. While counselors presumably know databases are
available, whether or not they are accessing these resources has not been assessed.

Therefore, this study was designed to ask practicing genetic counselors how they are
processing VUS results and whether or not they are using genomic databases to compare
classifications.
Though the NSGC has released a statement encouraging the sharing of genetic variant data
by laboratories, genetic counselors’ opinions on the relative importance of this and other
laboratory attributes have not been investigated. Additionally, this study aimed to uncover
whether or not genetic counselors incorporate a laboratory’s data sharing practices when
choosing a testing laboratory.
Methods
Study Design
This study received exemption from Sarah Lawrence College’s Institutional Review Board in
November of 2015. An email was sent in January 2016 by NSGC to all of its members who
had previously agreed to be contacted by students for research, inviting them to
participate. This email included a general description of the study, the informed consent
form, and the link to the survey. The survey, which was created using Survey Monkey, was
made up of 14 questions including four free response prompts.
Participants
Survey participants included laboratory and clinical genetic counselors who are members of
the NSGC. No direct contact occurred between the researchers and the participants. The
data from the survey was compiled at the end of February 2016 and a combined 216
responses were collected from both laboratory and clinical genetic counselors. In order to
fill out the survey, participants were asked to identify as either working in a clinical or
laboratory setting. If the participant worked in a clinical setting they had to have received a
VUS result for a patient at some point in their career in order to complete the remainder of
the survey.
Measures
Of the 216 total responses, 178 identified as clinical genetic counselors and 38 identified as
laboratory genetic counselors. Seven questions were asked only of clinical genetic
counselors and did not apply to counselors working for a laboratory. For example, only
clinical counselors were asked “Does whether or not a laboratory participates in data

sharing influence your decision to order tests from that company?” There were no
questions asked only of laboratory genetic counselors.
Data Analysis
Three types of questions were analyzed from the survey: multiple choice, Likert scale, and
free response.
Two of the survey questions with the multiple choice options of “yes” or “no” were asked to
both clinical and laboratory counselors. The answers to these questions were analyzed by
calculating the percentage of each response for both professional settings separately.
Two survey questions had three choice response options including: yes, no, or I do not have
a choice (referring to their role in choosing a laboratory for testing). These questions were
only asked of clinical genetic counselors.
Two survey questions used a Likert scale. Likert scale questions were used to assess genetic
counselor’s behavior toward contacting laboratories and searching databases.
The first free response survey question “Please list the databases you use to compare VUS
results?” was asked to both clinical and laboratory genetic counselors. The answers to this
question were analyzed for the number of times each specific database was mentioned and
for the total number of databases mentioned. The results were sorted by databases
mentioned more than or less than five times by clinical and laboratory counselors
combined.
The second free response question “Please use this space to include any additional
comments you may have about publicly shared databases or VUS classification.” was asked
to both clinical and laboratory genetic counselors. The responses to this question were
analyzed separately by two researchers to assess for recurrent themes.
Results
Only clinical counselors were asked “are you aware if the laboratories you order genetic
tests from participate in data sharing?” 91.01% (162) of all clinical counselors responded.
Results listed in Graph 1.

Graph 1
Are you aware if the laboratories you order genetic tests from participate in data sharing?

Both clinical and laboratory counselors were asked if they support the sharing of data by
clinical laboratories. 88.89% (192) of all participants responded to this question. 97.92%
(188) of both clinical and laboratory counselors combined said that they support the sharing
of data by clinical laboratories. Results listed in Graph 2.
Graph 2
Do you support the sharing of data by clinical laboratories?

Both clinical and laboratory counselors were asked if genetic counselors should encourage
clinical laboratories to share their variant interpretations. 88.89% (192) of all participants
responded to this question. 96.88% (186) of both clinical and laboratory counselors
combined said that genetic counselors should encourage clinical laboratories to share their
variant interpretation. Results listed in Graph 3.

Graph 3
Should genetic counselors encourage clinical laboratories to share their variant
interpretation?

Clinical counselors only were asked whether or not a laboratory’s VUS classification method
comes into consideration when they are choosing a laboratory to use for testing. Results
listed in Graph 4.
Graph 4
Does the laboratories VUS classification method come into consideration when you are
choosing from which laboratory to order testing from?

Clinical counselors were asked whether a laboratory’s data sharing practices influences their
decision to order testing from that company. Of those who have control over choosing a
laboratory, 66.14% said that they take the laboratory’s data sharing practices into
consideration. Results listed in Graph 5.

Graph 5
Does whether or not a laboratory participates in data sharing influence your decision to
order tests from that company?

Clinical counselors only were asked to rank on a Likert scale from 1 to 5 (1 being “almost
never” and 5 being “almost always”) how often they speak to the testing laboratory about a
specific VUS results. A total of 161 clinical genetic counselors responded to this question
and the mean likert score was 3.16. Results listed in Table 1.
Table 1
How often do you speak with the testing laboratory about a specific VUS result?
Likert score

Number of responses

Percentage

1 “almost never”

12

7.45%

2

34

21.12%

3 “sometimes”

53

32.92%

4

40

24.84%

5 “almost always

22

13.66%

Both clinical and laboratory genetic counselors were asked to rank on a Likert scale from 1
to 5 (1 being “almost never” and 5 being “almost always”) how often they search any
databases for conflicting or agreeing classification information for a VUS result. A total of

160 clinical genetic counselors responded to this question and the mean response score
was 3.68. Twenty-four laboratory genetic counselors responded to this question and the
mean response score was 3.83. Full results listed in Table 2.
Table 2
How often do you search any databases for conflicting or agreeing classification information
for a VUS result you have received?
Likert score

Number of responses

Percentage

1 “almost never”

23

14.38%

2

12

7.5%

3 “sometimes”

18

11.25%

4

47

29.38%

5 “almost always”

60

37.50%

1 “almost never”

5

20.83%

2

1

4.17%

3 “sometimes”

1

4.17%

4

3

12.50%

5 “almost always”

14

58.33%

Clinical counselors:

Laboratory counselors:

Both clinical and laboratory counselors were asked in a free response question to list the
databases they used to compare VUS results. A total of 138 (71.88%) clinical and laboratory
genetic counselors answered this question. Out of the 23 different databases mentioned,
nine databases were mentioned more than five times by all respondents combined. ClinVar
was mentioned the most amount of times by far with a total of 119, the second most
mentioned database was ClinVitae with 25. All databases mentioned five times or more are
listed in Table 3.

Table 3
Please list the databases you use to compare VUS results
Database

Description

Curator

Clinical

Laboratory

Total

ClinVar

Contains variants
submitted by various
laboratories/ groups
(~300). Variants are
classified on their
pathogenicity.

NCBI

105

14

119

ClinVitae

Contains variants
collected from six
different database
sources, including
Invitae and ClinVar.

Invitae

24

1

25

HGMD (Human
Gene Mutation
Database)

Data from variants that BIOBASE
are associated with
diseases reported in
the literature and links
to the publication(s)

14

8

22

ExAC (The
Exome
Aggregation
Consortium)

Data on ~60,000
people from
population studies and
disease specific groups

Broad
Institute

16

4

20

LOVD (Leiden
Open Variant
Database)

A gene centered
collection of variants

Leiden
University
Medical
Center

8

6

14

EVS (Exome
Variant Server)

Includes variants on
~6,500 people. Data
collected from both
unaffected people and
people from specific
disease groups.

NHLBI

9

2

11

Ethnicity is broken
down into European
Americans & African
Americans.
1000 Genomes

Data on ~2,500
NCBI
genomes without any
medical/ phenotypic
information. Can utilize
genomes based on
ethnicity (American,
East Asian, South
Asian, African, and
European)

7

2

9

dbSNP
(Database of
Single
Nucleotide
Polymorphism)

A collection of simple
genetic variations from
any type of organism,
including humans

NCBI

5

4

9

BIC (Breast
Cancer
Information
Core)

Variation database for
breast cancer
susceptibility genes

NIH

6

1

7

Both clinical and laboratory genetic counselors were given the option to include any
additional comments about publicly shared databases or VUS classification in a free
response question. A total of 65 (30.09%) participants chose to give a free response. This
response rate makes up a small section of our sample, therefore it may not be
representative of the whole sample. The themes found within these responses are further
analyzed in our discussion.

Discussion
Most genetic counselors believe that laboratories should share variant data in public
databases
When asked directly, all but one clinical genetic counselor (99.38%) and the majority of
laboratory genetic counselors (90.00%) said that they support the sharing of data by clinical
laboratories. When asked open ended questions about data sharing, 69.23% genetic
counselors who responded made positive comments about the use of public databases by
clinical laboratories in order to aide variant classification.
Eighteen counselors (27.69%) stated that all laboratories should contribute their data to
public databases. These counselors felt that databases are the solution to learning more
about variants and streamlining the classification process. As one respondent said:
“I think they should be utilized and I think all labs should contribute to them. Data should not
be considered private or corporate data- this is information that can affect lives and pooling
data may be a quick way to learn more about these variants.”
While the majority of counselors had strong beliefs that the sharing of variant data will
improve variant classification methods and patient care, there was one counselor that
strongly opposed data sharing:
“Data sharing will not make results more accurate or improve the quality of other lab’s test
results. If there is no reason to improve, competition, then innovation will be hampered.
Sharing data is just unrealistic.”
The overall consensus of these responses reflect the NSGC statement supporting public data
sharing. Genetic counselors surveyed were in agreement that commercial laboratories
should contribute their variant data and classification methods to public databases in order
to improve understanding and patient care.
Data sharing practices have some impact on genetic counselors’ choice of testing
laboratory
Genetic counselors overwhelmingly support the idea of laboratories sharing variant data,
but they are not uniformly supporting laboratories who share their data. Most (88.19%)
genetic counselors are in control of choosing which laboratory their patients receive testing

from. Genetic counselors have the ability to support laboratories who publically share their
variant data by choosing to order their patients’ testing from those laboratories.
The majority of clinical genetic counselors responding (79.01%) reported being aware of
whether or not the laboratories they order testing from participate in data sharing. Even if
data sharing is something genetic counselors are aware of, some (11.72%) are restricted in
their ability to personally select a laboratory for their patients’ testing. Of those who have
the ability to choose, most but not all (66.14%) actually take data sharing practices into
consideration when deciding a laboratory from which to order testing. While the majority
of clinical counselors do consider data sharing, it is “one of many factors” that counselors
are also taking into account when selecting a laboratory. Turnaround time, cost, continuity
in ordering from a laboratory previously used by a family member, and insurance
requirements are other factors that counselors take into account when choosing where to
order testing from.
Even if a genetic counselor firmly believes that laboratories should be sharing their variant
data, the counselor will only choose a laboratory that shares data over a laboratory that
does not if the tests are otherwise equal. One respondent added:
“I completely believe in data sharing, but I will admit that I will order from labs that don’t if
they have the best test for my specific patient … but if I have a choice between two
equivalent tests for a patient, I will chose a lab that data shares.”
Some counselors felt more strongly that sharing variant data shows transparency in how
variant classification is performed and demonstrates overall more trustworthy, accurate
variant classification:
“The withholding of variant data so it can have a (perceived or real) competitive advantage
over other labs is unethical. Until internal laboratory variant classification
algorithms/software is externally validated, I have no proof that claims of superior variant
classification are true. All other things being equal, I send samples to labs that share data,
and will continue to do so.”
Through choosing to order their patients’ testing from laboratories who participate in data
sharing, genetic counselors are assisting in increasing the amount of publically available
data.

Genetic counselors’ current practice after receiving a VUS result is not uniform
Genetic counselors react in different ways after receiving a VUS result for a patient. Clinical
genetic counselors are spread across the spectrum of “almost always” (37.50%) to “almost
never” (14.38%) searching databases for conflicting or agreeing classification information
for a VUS result. This same variation in practice is seen in how often clinical genetic
counselors follow up with a laboratory directly after receiving a VUS result, where 32.92%
indicate that they “sometimes” follow up. Laboratory and clinical genetic counselors
collectively reported using 32 different specific databases. Only nine of these databases
were named by more than five of the responding genetic counselors (Table 3). The 23 other
databases were only mentioned one to two times; these responses consisted largely of
disease or gene specific databases and may be specific to the counselor’s area of practice.
For example, POLG Mutation Database and SCN1a Variant Database were each mentioned
once. These results highlight the inconsistencies in practice among genetic counselors when
are providing care to patients who receive a VUS result.
While there is variability in how often counselors are following up with laboratories and
databases after receiving a VUS result, the majority of counselors are using both of these
resources. 71% of clinical genetic counselors “sometimes” to “always” follow up with a
laboratory about the classification of a VUS result they received from the laboratory. 78% of
clinical and 75% of laboratory genetic counselors “sometimes” to “always” search databases
for conflicting or agreeing classification information on a VUS result. More clinical genetic
counselors (125) report searching public databases than the number (115) that report
calling the laboratory in regards to a VUS result. The frequent use of public databases by
clinical genetic counselors highlights the importance of these databases for patient care.
There were some explanations given for why genetic counselors who support data sharing
chose not to use public databases for patient care. When asked to comment, a small
number of clinical counselors stated that they trust the testing laboratories classification
implicitly and do not refer to any databases:
“As a clinical genetic counselor, I largely rely on the testing laboratory’s established methods
for classifying variants and often don’t look too much into it or question their reasoning
when I receive results.”
Additionally, 7 out of 51 clinical counselors (13.73%) stated that they do not know how to
use databases. Many of these counselors also expressed a wish for some kind of education
or formal training on how to access and use databases:

“I found that as a student, my training did not prepare me to do my own variant
interpretation using databases. On the job, I have also not had adequate training about how
to use these databases. I think this is a barrier to using these databases and attempting to
interpret VUS classifications.”
Responses like these highlight the need for educational opportunities for genetic counselors
reviewing the use of variant databases to allow them to incorporate them into their
practice. The inconsistencies in databases and resources used among counselors further
highlight the unfamiliarity of practicing clinicians with this topic. Continuing education for
clinical genetic counselors on how to incorporate public variant databases into their
practice may help create a uniform standard of care for patients with a VUS result.
Study Limitations
This study was limited by the small overall sample size. Between January 4 and February 29,
2016 a total of 216 genetic counselors responded to the survey. Some of these counselors
answered only select questions resulting in a 91.52% completion rate by clinical counselors
and at 87.37% completion rate by laboratory counselors. Since each question of the survey
was designed to stand alone, no surveys were discarded due to incomplete responses.
This study was also limited by the small uptake of the survey by laboratory counselors.
Thirty-eight out of 216 respondents identified as laboratory genetic counselors. According
the 2014 professional status survey by NSGC 76% of genetic counselors work in a clinical
position and 14% work as non-clinical genetic counselors (NSGC Headquarters, 2015).
While, skewed due to increased response from clinical genetic counselors the responses
received accurately reflect the distribution of genetic counselors in the field.
Conclusion
Our survey shows both clinical and laboratory genetic counselors stand behind the NSGC
statement supporting the sharing of variant data, especially by clinical testing laboratories.
The majority of clinical counselors are putting this support into action by allowing a
laboratory’s data sharing practices to influence their decision on which laboratory to order
testing from. At this time, data sharing practices by laboratories is only one of many
considerations that impact genetic counselor's decisions regarding choice of testing
laboratory.
Genetic counselors have been called upon to incorporate the use of public databases into
clinical care in order to help patients make medical decisions based on an uncertain result

(Ormond et al, 2015). This study shows that most genetic counselors are using variant
databases after receiving a VUS result for a patient. But the use of these databases by
genetic counselors is far from uniform. Clinical genetic counselors are using a wide variety
of genomic databases inconsistently. This inconsistency highlights that counselors need
more education on how to use public genomic databases for the benefit of patient care.
Adopting a standardized process regarding the handling of a VUS by genetic counselors
would ultimately benefit patient care.
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